Skip to content

13F-HR filed by SECTORAL ASSET MANAGEMENT INC

SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-10, with 55 holding rows worth $902,673,000.

Accession
0001104659-17-008034
Filed
2017-02-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 55 entries on the cover page, a total value of $902,673,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $902,673,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Merck & Co.,Inc.58933Y105COM973,832$57,329,000thousands by filing date
Pfizer Inc.717081103COM1,764,343$57,306,000thousands by filing date
Eli Lilly and Company532457108COM729,117$53,627,000thousands by filing date
CELGENE CORP151020104COM433,981$50,233,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM492,100$40,766,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM1,176,543$33,932,000thousands by filing date
NUVASIVE INC670704105COM498,689$33,592,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM2,104,756$32,771,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock1,419,404$31,851,000thousands by filing date
DEXCOM INC COM252131107Stock509,836$30,437,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock886,405$29,340,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM748,988$28,986,000thousands by filing date
CIGNA CORPORATION125509109COM212,424$28,335,000thousands by filing date
ABIOMED INC003654100COM251,416$28,330,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO158,158$26,947,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM42,416$26,899,000thousands by filing date
TELADOC HEALTH INC87918A105COM1,569,878$25,903,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM5,100,198$25,348,000thousands by filing date
BIOGEN INC COM09062X103Stock84,841$24,059,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK891,313$23,361,000thousands by filing date
AETNA INC NEW00817Y108COM182,185$22,593,000thousands by filing date
KITE PHARMA INC49803L109COM372,223$16,690,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM1,125,801$16,268,000thousands by filing date
ACCURAY INC DEL004397105COM3,072,536$14,134,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM669,351$13,923,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS458,977$10,547,000thousands by filing date
NEURODERM LTDM74231107ORD SHS440,799$9,786,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM235,298$8,906,000thousands by filing date
ACCELERON PHARMA INC00434H108COM345,225$8,810,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR236,380$8,477,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM74,150$8,056,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM125,040$7,914,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM136,845$7,425,000thousands by filing date
INTERSECT ENT INC46071F103COM534,937$6,473,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock123,646$6,082,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW69,200$5,937,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM379,500$5,711,000thousands by filing date
ADVAXIS INC007624208COM NEW690,074$4,941,000thousands by filing date
SURGICAL CARE AFFILIATES INC COM86881L106Stock98,300$4,548,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM252,940$3,842,000thousands by filing date
INCYTE CORP COM45337C102Stock34,374$3,447,000thousands by filing date
K2M GROUP HLDGS INC48273J107COM155,450$3,115,000thousands by filing date
ENTELLUS MED INC29363K105COM130,496$2,476,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM54,900$2,291,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR32,155$1,456,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM27,899$1,425,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock103,300$1,367,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR38,401$1,349,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM123,135$1,343,000thousands by filing date
AVEXIS INC05366U100COM23,215$1,108,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM28,799$790,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock19,899$745,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock100,000$565,000thousands by filing date
PROFOUND MED CORP74319B106COM495,900$414,000thousands by filing date
PRONAI THERAPEUTICS074346L10COMMON201,660$367,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-17-008034this filing2017-02-10acceptance time not in the bulk data set